Journal article · 2017 · Open access
The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance
PLoS ONE, 12(2), e0172488 · Published 23 February 2017 · DOI 10.1371/journal.pone.0172488
In brief
“The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance” is a 2017 journal article by Kenneth Fernald and 4 co-authors, published in PLoS ONE. OpenAlex counts 47 citations as of 19 November 2026. It is open access under a CC BY licence: the full text is free to read at PLoS ONE.
- Citations
- 47
- Most cited in
- 2018 (7)
- Field-weighted impact
- 6.39
- References
- 95
- Authors
- 5
Abstract
In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters' patent expirations, this paper examines the moderating role of firms' absorptive capacity in external innovation activities of Big Pharma firms. The study indicates a rising interest of Big Pharma in acquisitions of and alliances with biotechnology companies. Unfortunately, this increased interest is not reflected in the number of new drugs generated by Big Pharma. We find that acquisitions of biotech companies have negatively affected Big Pharma firms' innovation performance on average but these acquisitions might have a positive effect at higher levels of acquiring firms' absorptive capacity. Moreover, also acquisitions of pharma companies and alliances with biotech companies only have a positive effect on innovation performance at sufficiently high levels of absorptive capacity. The moderating role of absorptive capacity implicates that a tight integration of internal R&D efforts and (unrelated) external knowledge is crucial for harnessing complementarity effects.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Fernald, K., Pennings, E., van den Bosch, J. F., Commandeur, H. R., & Claassen, E. (2017). The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance. PLoS ONE, 12(2), e0172488. https://doi.org/10.1371/journal.pone.0172488
MLA 9
Fernald, Kenneth, et al. “The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.” PLoS ONE, vol. 12, no. 2, 2017, p. e0172488. https://doi.org/10.1371/journal.pone.0172488.
Chicago
Fernald, Kenneth, Enrico Pennings, J. F. van den Bosch, Harry R. Commandeur, and Eric Claassen. 2017. “The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.” PLoS ONE 12 (2): e0172488. https://doi.org/10.1371/journal.pone.0172488.
Harvard
Fernald, K. et al. (2017) ‘The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance’, PLoS ONE, 12(2), p. e0172488. doi:10.1371/journal.pone.0172488.
IEEE
K. Fernald, E. Pennings, J. F. van den Bosch, H. R. Commandeur, and E. Claassen, “The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance,” PLoS ONE, vol. 12, no. 2, p. e0172488, 2017, doi: 10.1371/journal.pone.0172488.
BibTeX
@article{fernald2017moderating,
title = {{The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance}},
author = {Fernald, Kenneth and Pennings, Enrico and van den Bosch, J. F. and Commandeur, Harry R. and Claassen, Eric},
journal = {PLoS ONE},
year = {2017},
volume = {12},
number = {2},
pages = {e0172488},
doi = {10.1371/journal.pone.0172488},
url = {https://doi.org/10.1371/journal.pone.0172488}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2015 | 1 | |
| 2018 | 7 | |
| 2019 | 6 | |
| 2020 | 6 | |
| 2021 | 6 | |
| 2022 | 3 | |
| 2023 | 7 | |
| 2024 | 7 | |
| 2025 | 1 | |
| 2026 | 3 |
Its field-weighted citation impact is 6.39: it has been cited 6.39 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Social Sciences › Business, Management and Accounting › Strategy and Management › Innovation and Knowledge Management
- absorptive capacity
- pharmaceutical industry
- mergers and acquisitions
- strategic alliances
- biotechnology companies
- innovation performance
- external knowledge
- R&D complementarity
Work with this paper
Most-cited papers in Business, Management and Accounting
- Firm Resources and Sustained Competitive AdvantageJay Bryan Barney · Journal of Management · 1991 · 57,081 citations
- The Iron Cage Revisited: Institutional Isomorphism and Collective Rationality in Organizational FieldsPaul DiMaggio, Walter W. Powell · American Sociological Review · 1983 · 42,816 citations
- Building Theories from Case Study ResearchKathleen M. Eisenhardt · Academy of Management Review · 1989 · 39,809 citations
- Firm resources and sustained competitive advantageJay Bryan Barney · Advances in strategic management · 2004 · 38,183 citations
- Absorptive Capacity: A New Perspective on Learning and InnovationWesley M. Cohen, Daniel A. Levinthal · Administrative Science Quarterly · 1990 · 37,030 citations
Questions about this paper
How do I cite this paper in APA style?
Fernald, K., Pennings, E., van den Bosch, J. F., Commandeur, H. R., & Claassen, E. (2017). The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance. PLoS ONE, 12(2), e0172488. https://doi.org/10.1371/journal.pone.0172488
How many times has this paper been cited?
47 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at PLoS ONE: sign in and open the PDF from this page.
Who wrote this paper?
Kenneth Fernald, Enrico Pennings, J. F. van den Bosch, Harry R. Commandeur, Eric Claassen.
What is the DOI of this paper?
10.1371/journal.pone.0172488, permanently at https://doi.org/10.1371/journal.pone.0172488. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.